SG11202102688PA - Surface modified extracellular vesicles - Google Patents
Surface modified extracellular vesiclesInfo
- Publication number
- SG11202102688PA SG11202102688PA SG11202102688PA SG11202102688PA SG11202102688PA SG 11202102688P A SG11202102688P A SG 11202102688PA SG 11202102688P A SG11202102688P A SG 11202102688PA SG 11202102688P A SG11202102688P A SG 11202102688PA SG 11202102688P A SG11202102688P A SG 11202102688PA
- Authority
- SG
- Singapore
- Prior art keywords
- surface modified
- extracellular vesicles
- modified extracellular
- vesicles
- modified
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6901—Conjugates being cells, cell fragments, viruses, ghosts, red blood cells or viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
- A61K47/6835—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/485—Epidermal growth factor [EGF], i.e. urogastrone
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/52—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/22—Cysteine endopeptidases (3.4.22)
- C12Y304/2207—Sortase A (3.4.22.70)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
- C07K2319/21—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a His-tag
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
- C07K2319/42—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation containing a HA(hemagglutinin)-tag
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
- C07K2319/43—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation containing a FLAG-tag
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Immunology (AREA)
- Cell Biology (AREA)
- Biochemistry (AREA)
- Virology (AREA)
- Hematology (AREA)
- Gastroenterology & Hepatology (AREA)
- Wood Science & Technology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Toxicology (AREA)
- Biophysics (AREA)
- Dispersion Chemistry (AREA)
- Developmental Biology & Embryology (AREA)
- Microbiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201862734303P | 2018-09-21 | 2018-09-21 | |
US201862776009P | 2018-12-06 | 2018-12-06 | |
PCT/SG2019/050481 WO2020060496A1 (en) | 2018-09-21 | 2019-09-20 | Surface modified extracellular vesicles |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11202102688PA true SG11202102688PA (en) | 2021-04-29 |
Family
ID=69887697
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11202102688PA SG11202102688PA (en) | 2018-09-21 | 2019-09-20 | Surface modified extracellular vesicles |
Country Status (6)
Country | Link |
---|---|
US (1) | US20210353769A1 (zh) |
EP (1) | EP3852770A4 (zh) |
JP (1) | JP2022513312A (zh) |
CN (1) | CN112996543A (zh) |
SG (1) | SG11202102688PA (zh) |
WO (1) | WO2020060496A1 (zh) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2023511271A (ja) * | 2020-01-13 | 2023-03-17 | カーマイン・セラピューティクス・プライベート・リミテッド | 核酸搭載細胞外小胞 |
WO2023175016A1 (en) * | 2022-03-15 | 2023-09-21 | Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts | Method for producing delivery vesicles |
CN114522252B (zh) * | 2022-04-24 | 2023-08-04 | 天津外泌体科技有限公司 | 一步法叠氮化修饰细胞外囊泡的方法及修饰试剂 |
CN114973245B (zh) * | 2022-06-20 | 2024-03-15 | 重庆医科大学 | 基于机器学习的细胞外囊泡分类方法、装置、设备及介质 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20140030697A1 (en) * | 2012-06-14 | 2014-01-30 | Massachusetts Institute Of Technology | Sortase-mediated modification of viral surface proteins |
AU2014262469B2 (en) * | 2013-05-10 | 2019-11-14 | Whitehead Institute For Biomedical Research | Protein modification of living cells using sortase |
WO2015002956A1 (en) * | 2013-07-01 | 2015-01-08 | Ohio State Innovation Foundation | Exosome delivery system |
WO2016014553A1 (en) * | 2014-07-21 | 2016-01-28 | Novartis Ag | Sortase synthesized chimeric antigen receptors |
WO2017118764A1 (en) * | 2016-01-07 | 2017-07-13 | Thomas Brocker | Novel approaches for the in vivo and in vitro visualization of dying cells |
-
2019
- 2019-09-20 WO PCT/SG2019/050481 patent/WO2020060496A1/en active Search and Examination
- 2019-09-20 SG SG11202102688PA patent/SG11202102688PA/en unknown
- 2019-09-20 US US17/278,280 patent/US20210353769A1/en active Pending
- 2019-09-20 EP EP19862222.7A patent/EP3852770A4/en active Pending
- 2019-09-20 CN CN201980062155.9A patent/CN112996543A/zh active Pending
- 2019-09-20 JP JP2021541013A patent/JP2022513312A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
JP2022513312A (ja) | 2022-02-07 |
EP3852770A4 (en) | 2022-09-14 |
US20210353769A1 (en) | 2021-11-18 |
WO2020060496A1 (en) | 2020-03-26 |
CN112996543A (zh) | 2021-06-18 |
EP3852770A1 (en) | 2021-07-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL277344A (en) | Extracellular vesicles containing agonist-STING | |
IL283167A (en) | Engineered extracellular vesicles and their uses | |
EP3661556A4 (en) | SYNTHETIC EXTRACELLULAR VESICLES FOR NEW THERAPIES | |
GB201612643D0 (en) | Surface decoration of extracellular vesicles | |
PL3888519T3 (pl) | Urządzenie do czyszczenia powierzchni | |
IL246997A0 (en) | Antibodies against the extracellular domain of (muc1-c (muc1-c/ecd | |
IL263727A (en) | Extracellular vesicles with enhanced strength | |
IL274124A (en) | Protein engineered extracellular vesicles | |
PL3501363T3 (pl) | Urządzenie do czyszczenia powierzchni | |
HK1247964A1 (zh) | 用於活性劑遞送的細胞外囊泡 | |
IL280658A (en) | Extracellular vesicles for inhalation | |
SG11202102688PA (en) | Surface modified extracellular vesicles | |
GB2572303B (en) | Surface cleaning apparatus | |
IL280851A (en) | Targeted extracellular vesicles | |
SG11202003499YA (en) | Immunomodulatory composition comprising lactobacillus-derived extracellular vesicles | |
GB201812992D0 (en) | Liposomes | |
GB201802105D0 (en) | Nozzle | |
GB2564499B (en) | Flow-adjustable shower unit | |
GB201801634D0 (en) | # | |
GB201808285D0 (en) | Labelling of extracellular vesicles | |
GB2562698B (en) | Surface cleaning apparatus | |
GB201706993D0 (en) | Method for obtaning extracellular vesicles | |
GB2576971B (en) | Underlay | |
GB2580582B (en) | Felting Frame | |
GB201811863D0 (en) | Wipes |